A Study of Ceftazidime-Avibactam in Newborns and Infants Less Than 3 Months Old With Suspected or Confirmed Infections Due to Gram-Negative Bacteria That Needed Intravenous Antibiotic Treatment
A Phase 2a, 2-Part, Open-Label, Non-Randomized, Multicenter, Single and Multiple Dose Trial to Evaluate Pharmacokinetics, Safety and Tolerability of Ceftazidime and Avibactam in Neonates and
Infants From Birth to Less Than 3 Months of Age With Suspected or Confirmed Infections due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment.
Category & Conditions: Infections and Infectious Diseases
Medicine: Zavicefta (ceftazidime-avibactam)
ClinicalTrials.gov Identifier (NCT): NCT04126031
Protocol ID: C3591024
PrintDownloadOpen Plain Language Summary Result: Click here